Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1435 | 2668 | 44.5 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
296 | 3 | BREAST//BREAST CANCER//LYMPHEDEMA | 41323 |
2107 | 2 | LYMPHANGIOGENESIS//VEGF C//PODOPLANIN | 5136 |
1435 | 1 | LYMPHANGIOGENESIS//VEGF C//VEGFR 3 | 2668 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LYMPHANGIOGENESIS | authKW | 4429525 | 24% | 60% | 649 |
2 | VEGF C | authKW | 2124818 | 11% | 63% | 297 |
3 | VEGFR 3 | authKW | 1239120 | 6% | 70% | 154 |
4 | VASCULAR ENDOTHELIAL GROWTH FACTOR C | authKW | 1056702 | 5% | 71% | 130 |
5 | VEGF D | authKW | 788306 | 4% | 73% | 95 |
6 | LYMPHATIC ENDOTHELIAL CELLS | authKW | 786638 | 4% | 63% | 110 |
7 | PROX1 | authKW | 728480 | 4% | 54% | 117 |
8 | LYVE 1 | authKW | 591114 | 3% | 64% | 81 |
9 | LYMPHATIC VESSELS | authKW | 562107 | 5% | 37% | 133 |
10 | MOL CANC BIOL | address | 524175 | 6% | 31% | 150 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 6284 | 26% | 0% | 701 |
2 | Pathology | 2867 | 10% | 0% | 262 |
3 | Cell Biology | 1850 | 15% | 0% | 403 |
4 | Anatomy & Morphology | 1487 | 3% | 0% | 91 |
5 | Developmental Biology | 1285 | 5% | 0% | 127 |
6 | Medicine, Research & Experimental | 1187 | 9% | 0% | 238 |
7 | Peripheral Vascular Diseases | 581 | 5% | 0% | 135 |
8 | Physiology | 526 | 6% | 0% | 155 |
9 | Hematology | 468 | 5% | 0% | 129 |
10 | Immunology | 382 | 8% | 0% | 202 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL CANC BIOL | 524175 | 6% | 31% | 150 |
2 | EYE DIS DEV | 193982 | 1% | 63% | 27 |
3 | PROGRAM VIS SCI | 160399 | 1% | 52% | 27 |
4 | TRANSLAT CANC BIOL PROGRAM | 104502 | 1% | 35% | 26 |
5 | TUMOUR ANGIOGENESIS PROGRAM | 86719 | 0% | 63% | 12 |
6 | WIHURI | 86695 | 1% | 32% | 24 |
7 | LYMPHAT DEV | 82382 | 0% | 60% | 12 |
8 | BIOMEDICUM HELSINKI | 60870 | 3% | 7% | 77 |
9 | MOL CANC UNITSAKYO KU | 45773 | 0% | 100% | 4 |
10 | TUMOUR ANGIOGENESIS MICROENVIRONM PROGRAM | 45773 | 0% | 100% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LYMPHOLOGY | 71894 | 3% | 8% | 82 |
2 | LYMPHATIC RESEARCH AND BIOLOGY | 36446 | 1% | 13% | 25 |
3 | NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES A, LIFE SCIENCES | 7143 | 1% | 4% | 15 |
4 | ADVANCES IN ANATOMY EMBRYOLOGY AND CELL BIOLOGY | 6833 | 0% | 6% | 10 |
5 | AMERICAN JOURNAL OF PATHOLOGY | 3278 | 2% | 0% | 61 |
6 | MICROVASCULAR RESEARCH | 2445 | 1% | 1% | 24 |
7 | MICROCIRCULATION | 1519 | 0% | 1% | 12 |
8 | DEVELOPMENTAL DYNAMICS | 1152 | 1% | 0% | 22 |
9 | ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY | 1016 | 0% | 1% | 13 |
10 | NEOPLASIA | 956 | 0% | 1% | 12 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LYMPHANGIOGENESIS | 4429525 | 24% | 60% | 649 | Search LYMPHANGIOGENESIS | Search LYMPHANGIOGENESIS |
2 | VEGF C | 2124818 | 11% | 63% | 297 | Search VEGF+C | Search VEGF+C |
3 | VEGFR 3 | 1239120 | 6% | 70% | 154 | Search VEGFR+3 | Search VEGFR+3 |
4 | VASCULAR ENDOTHELIAL GROWTH FACTOR C | 1056702 | 5% | 71% | 130 | Search VASCULAR+ENDOTHELIAL+GROWTH+FACTOR+C | Search VASCULAR+ENDOTHELIAL+GROWTH+FACTOR+C |
5 | VEGF D | 788306 | 4% | 73% | 95 | Search VEGF+D | Search VEGF+D |
6 | LYMPHATIC ENDOTHELIAL CELLS | 786638 | 4% | 63% | 110 | Search LYMPHATIC+ENDOTHELIAL+CELLS | Search LYMPHATIC+ENDOTHELIAL+CELLS |
7 | PROX1 | 728480 | 4% | 54% | 117 | Search PROX1 | Search PROX1 |
8 | LYVE 1 | 591114 | 3% | 64% | 81 | Search LYVE+1 | Search LYVE+1 |
9 | LYMPHATIC VESSELS | 562107 | 5% | 37% | 133 | Search LYMPHATIC+VESSELS | Search LYMPHATIC+VESSELS |
10 | LYMPHATIC VESSEL DENSITY | 337451 | 2% | 72% | 41 | Search LYMPHATIC+VESSEL+DENSITY | Search LYMPHATIC+VESSEL+DENSITY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DIETERICH, LC , DETMAR, M , (2016) TUMOR LYMPHANGIOGENESIS AND NEW DRUG DEVELOPMENT.ADVANCED DRUG DELIVERY REVIEWS. VOL. 99. ISSUE . P. 148 -160 | 156 | 76% | 6 |
2 | STACKER, SA , WILLIAMS, SP , KARNEZIS, T , SHAYAN, R , FOX, SB , ACHEN, MG , (2014) LYMPHANGIOGENESIS AND LYMPHATIC VESSEL REMODELLING IN CANCER.NATURE REVIEWS CANCER. VOL. 14. ISSUE 3. P. 159-172 | 134 | 71% | 109 |
3 | ASPELUND, A , ROBCIUC, MR , KARAMAN, S , MAKINEN, T , ALITALO, K , (2016) LYMPHATIC SYSTEM IN CARDIOVASCULAR MEDICINE.CIRCULATION RESEARCH. VOL. 118. ISSUE 3. P. 515 -530 | 119 | 69% | 11 |
4 | KARPANEN, T , ALITALO, K , (2008) MOLECULAR BIOLOGY AND PATHOLOGY OF LYMPHANGIOGENESIS.ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE. VOL. 3. ISSUE . P. 367-397 | 116 | 81% | 189 |
5 | SLEEMAN, JP , THIELE, W , (2009) TUMOR METASTASIS AND THE LYMPHATIC VASCULATURE.INTERNATIONAL JOURNAL OF CANCER. VOL. 125. ISSUE 12. P. 2747-2756 | 124 | 80% | 102 |
6 | THIELE, W , SLEEMAN, JP , (2006) TUMOR-INDUCED LYMPHANGIOGENESIS: A TARGET FOR CANCER THERAPY?.JOURNAL OF BIOTECHNOLOGY. VOL. 124. ISSUE 1. P. 224-241 | 135 | 89% | 57 |
7 | TAMMELA, T , ALITALO, K , (2010) LYMPHANGIOGENESIS: MOLECULAR MECHANISMS AND FUTURE PROMISE.CELL. VOL. 140. ISSUE 4. P. 460-476 | 93 | 63% | 482 |
8 | NORRMEN, C , TAMMELA, T , PETROVA, TV , ALITALO, K , (2011) BIOLOGICAL BASIS OF THERAPEUTIC LYMPHANGIOGENESIS.CIRCULATION. VOL. 123. ISSUE 12. P. 1335 -1351 | 129 | 70% | 52 |
9 | SUNDAR, SS , GANESAN, TS , (2007) ROLE OF LYMPHANGIOGENESIS IN CANCER.JOURNAL OF CLINICAL ONCOLOGY. VOL. 25. ISSUE 27. P. 4298 -4307 | 113 | 90% | 66 |
10 | BETTERMAN, KL , HARVEY, NL , (2016) THE LYMPHATIC VASCULATURE: DEVELOPMENT AND ROLE IN SHAPING IMMUNITY.IMMUNOLOGICAL REVIEWS. VOL. 271. ISSUE 1. P. 276 -292 | 104 | 66% | 5 |
Classes with closest relation at Level 1 |